泌尿器科手術デバイス市場：手技タイプ、エンドユーザー用途、地域別、2024年～2031年

泌尿器科手術デバイス市場の評価、2024年～2031年

前立腺がん、腎結石、尿失禁など、泌尿器科の問題はますます一般的になっています。このような病気が蔓延するにつれ、より優れた診断・手術技術へのニーズが高まり、2024年には394億7,000万米ドルを超え、2031年には573億9,000万米ドルに達します。

さらに、低侵襲治療への動向やロボット支援技術の導入は、手術精度の向上、療養時間の短縮、患者の転帰の改善によって市場拡大を後押ししています。イメージングやデバイス材料の改良などの技術的ブレークスルーは、より効果的で低侵襲な代替治療を提供することで市場を前進させ、2024年から2031年までのCAGRは約4.79%で成長すると予想されます。

泌尿器科手術デバイス市場定義/概要

泌尿器科手術デバイスとは、尿路や男性生殖器系を含む泌尿器科疾患の診断、治療、管理に使用される特殊な器具や機器です。これらの機器には、低侵襲手術用器具、ロボット支援システム、画像診断機器などが含まれます。泌尿器科手術用機器は、腎結石、前立腺がん、尿失禁、膀胱疾患など、さまざまな疾患の治療に使用されます。これらの機器は、低侵襲手術や従来のアプローチをより現実的なものにし、その結果、患者の予後を改善し、回復時間を短縮します。泌尿器科手術デバイスの将来は、ロボット手術、画像技術の向上、より良い診断と治療のためのスマート機器などの技術的進歩により、有望と思われます。継続的な技術革新により、精度の向上、侵襲性の低減、患者の快適性の向上が図られ、複雑な泌尿器科疾患の治療におけるこれらの機器の適用範囲と有効性が広がっています。

高齢者人口の増加は泌尿器科手術デバイス市場を牽引するか？

高齢者人口の増加は、泌尿器科手術デバイス市場の拡大を後押しする可能性が高いです。世界人口の高齢化に伴い、前立腺肥大症（BPH）、尿失禁、腎結石など、加齢に関連する泌尿器疾患が一般的になっています。これらの疾患は高齢者に多く、診断・治療用泌尿器科機器の需要が増加しています。

経済的な側面からは、高齢者人口の増加が、泌尿器科手術デバイスへの投資を含むヘルスケア支出のブームを牽引しています。高齢者は頻繁に医療を必要とするため、ヘルスケア費用の増加につながります。この人口動態の変化により、公的・民間ヘルスケア部門は泌尿器科手術により多くのリソースを割くようになり、その結果、手術器具の売上が増加しています。さらに、より先進的で低侵襲な手術技術に対する需要が、メーカーにとっての市場の可能性を高めています。医療従事者は、高齢患者の回復期間を短縮し、より良い結果を得ようと努力しているからです。

技術的には、高齢者人口の増加により、高齢患者特有のニーズを満たす泌尿器科手術器具の技術革新が進んでいます。低侵襲手術、ロボット支援手術、高度な画像技術は、高齢患者の手術の精度を高め、問題を減らすために使用されています。業界が高齢化社会に適応するにつれ、メーカーは虚弱や併存疾患など、高齢患者が直面する特定の問題に対処する最先端製品の開発に投資しています。このような技術向上への欲求は、患者の転帰を改善し、泌尿器科手術デバイス市場全体の成長に寄与しています。

手術機器コストの上昇は泌尿器科手術デバイス市場の成長を妨げるか？

手術装置コストの上昇は、泌尿器科手術装置産業の拡大の妨げになる可能性があります。高度な泌尿器科手術器具のコストが上昇すると、ヘルスケアプロバイダーは予算の制約に直面し、新技術を採用する能力が制限される可能性があります。これは、ヘルスケア予算が限られている地域や、コストに敏感な低所得者層にとって特に重要です。こうしたガジェットへの支出が増加すると、採用率が低下し、最先端機器へのアクセスが制限されることで市場全体の成長が阻害される可能性があります。

例えば、2024年5月、ヘルスケアコスト研究所は、ロボット手術システムや高度画像機器などのハイエンド泌尿器科技術の価格が大幅に上昇したと報告しました。報告書によると、これらの技術は精度と治療成績を向上させるが、その高額な費用が医療施設、特に裕福でない地域の医療施設に財政的な圧迫を与えています。このような経済的圧力は、新技術の採用を停滞させ、市場成長に悪影響を及ぼす可能性があります。

しかし、費用増加の影響を相殺するための取り組みが進行中です。2024年6月、複数の大手泌尿器科機器メーカーが、独創的な価格戦略やヘルスケアプロバイダーとの提携を通じて、自社製品をより手頃な価格にする試みを発表しました。このような取り組みには、高度な泌尿器科機器の導入に対する経済的障壁を軽減することを目的とした、費用負担スキームや拡張可能な技術ソリューションが含まれます。コストの上昇は依然として問題であるが、こうした取り組みは市場成長のバランスを取り、高度な泌尿器科手術技術へのアクセスを増やすのに役立つと予測されます。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 泌尿器科手術デバイス市場：手技タイプ別

• 腎摘除術
• 膀胱摘出術
• 前立腺切除術
• 尿管鏡検査
• 結石破砕術
• 膀胱吊り上げ術
• 経尿道的前立腺切除術（TURP）

第5章 泌尿器科手術デバイス市場：エンドユーザー別

• 病院および診療所
• 外来手術センター（ASCs）

第6章 泌尿器科手術デバイス市場：用途別

• 前立腺肥大症（BPH）
• 尿路結石症（腎結石）
• 前立腺がん
• 尿失禁

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Olympus
• Boston Scientific
• Medtronic
• Teleflex
• Karl Storz
• Richard Wolf
• Coloplast
• Conmed
• Stryker
• Cook Medical

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Urology Surgical Devices Market Valuation - 2024-2031

Urological problems include prostate cancer, kidney stones, and urine incontinence are becoming increasingly common. As these illnesses become more prevalent, there is a greater need for better diagnostic and surgical technology growth surpassing USD 39.47 Billion in 2024 and reachingUSD 57.39 Billion by 2031.

Furthermore, the trend to minimally invasive treatments and the incorporation of robotic-assisted technologies help to drive market expansion by improving surgical precision, shortening recuperation times, and improving patient outcomes. Technological breakthroughs, such as improvements in imaging and device materials, drive the market forward by providing more effective and less invasive treatment alternatives is expected to grow at aCAGR of about 4.79% from 2024 to 2031.

Urology Surgical Devices Market: Definition/ Overview

Urology surgical devices are specialized instruments and equipment used to diagnose, treat, and manage urological disorders involving the urinary tract and male reproductive system. These gadgets include instruments for minimally invasive surgery, robotic-assisted systems, and diagnostic imaging equipment. Urology surgical devices are used to treat a variety of conditions, including kidney stones, prostate cancer, urine incontinence, and bladder diseases. They make minimally invasive operations and traditional approaches more feasible, resulting in better patient outcomes and shorter recovery times. The future of urology surgical equipment seems promising, because to technological breakthroughs such as robotic surgery, improved imaging techniques, and smart devices for better diagnoses and treatment. Continued innovation strives to improve precision, reduce invasiveness, and increase patient comfort, hence broadening the applicability and effectiveness of these devices in treating complicated urological disorders.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Rising Geriatric Population Drive the Urology Surgical Devices Market?

The growing elderly population is likely to boost the expansion of the urology surgical devices market. As the world's population ages, age-related urological disorders such benign prostatic hyperplasia (BPH), urine incontinence, and kidney stones become more common. These disorders are more common in older persons, which increases the demand for diagnostic and therapeutic urological devices.

From an economic aspect, the growing elderly population is driving a boom in healthcare spending, including investments in urology surgical instruments. Older persons frequently require medical attention, which leads to increased healthcare costs. This demographic transition causes both the public and commercial healthcare sectors to devote more resources to urological surgeries, resulting in higher sales of surgical instruments. Furthermore, the demand for more advanced and minimally invasive surgical technologies increases market potential for manufacturers, as healthcare practitioners strive to give better outcomes with shorter recovery periods for senior patients.

Technologically, the growing elderly population drives innovation in urology surgical instruments to satisfy the specific needs of older patients. Minimally invasive procedures, robotic-assisted operations, and advanced imaging technologies are being used to increase precision and reduce problems in elderly patients' surgeries. As the industry adjusts to suit the aging population, manufacturers invest in the creation of cutting-edge products that address specific issues that older patients confront, such as frailty and comorbidities. This desire for technological improvement improves patient outcomes and contributes to the overall growth of the urology surgical equipment market.

Will Rising Surgical Device Cost Hinder the Growth of the Urology Surgical Devices Market?

Rising surgical device costs may represent a hindrance to the expansion of the urology surgical devices industry. As the cost of sophisticated urology surgical instruments rises, healthcare providers may confront budget constraints that limit their capacity to adopt new technologies. This is especially important in regions with limited healthcare budgets or in low-income communities where cost sensitivity is strong. Increased spending on these gadgets may result in slower adoption rates and impede overall market growth by limiting access to cutting-edge equipment.

For instance, in May 2024, the Healthcare Cost Institute reported a considerable increase in the pricing of high-end urological technology, such as robotic surgical systems and advanced imaging instruments. According to the report, while these technologies improve precision and outcomes, their high costs put a financial pressure on healthcare facilities, particularly those in less affluent communities. This financial pressure may cause a sluggish adoption of new technology, thereby harming market growth.

However, initiatives are underway to offset the effects of increased expenses. In June 2024, several major urological device makers announced attempts to make their products more affordable through creative pricing strategies and collaborations with healthcare providers. These efforts include cost-sharing schemes and scalable technological solutions that aim to reduce the financial barrier to adopting sophisticated urological devices. While rising costs are still a problem, these initiatives are projected to help balance market growth and increase access to sophisticated urology surgical technology.

Category-Wise Acumens

Will Rising Usage of Ureteroscopy Drive the Urology Surgical Devices Market?

The increasing use of ureteroscopy is projected to drive the urology surgical devices market significantly. Ureteroscopy is a minimally invasive treatment that diagnoses and treats ureter and kidney diseases such as stones, tumors, and strictures. Its growing popularity is largely due to the procedure's success in treating these problems with shorter recovery times and fewer complications than traditional surgical treatments. As more patients and healthcare providers realize the benefits of ureteroscopy, its popularity grows, resulting in growing demand for specialized ureteroscopic instruments.

In May 2024, Olympus Corporation announced the launching of its next-generation flexible ureteroscope, which is expected to provide greater picture quality and agility. This innovative gadget intends to improve procedure outcomes and patient comfort, reflecting the growing desire for ureteroscopy in clinical practice. The launch of such novel equipment contributes to the increased demand for ureteroscopy and drives the growth of the urology surgical devices market.

Furthermore, healthcare institutions and legislative improvements have helped to boost the number of preventive and diagnostic urological treatments performed. For instance, in July 2024, the American Urological Association (AUA) issued guidelines advocating ureteroscopy for specific cases of kidney stones and ureteral obstruction. This endorsement from a renowned professional association promotes the use of ureteroscopy, boosting market growth by increasing the number of procedures performed and stimulating demand for better ureteroscopic technology.

Lithotripsy is the fastest-growing segment due to its non-invasive nature and effectiveness in removing kidney stones, which has increased in popularity. The expansion is aided by technical advancements that improve the precision and efficiency of lithotripsy procedures, catering to a larger patient population seeking less intrusive treatment options.

Will Rising Cases of Urolithiasis (Kidney Stones) Drive the Growth of Urology Surgical Devices Market?

The increasing prevalence of Urolithiasis (kidney stones) is likely to cause considerable growth in the urology surgical device market. Kidney stones are a prevalent ailment that affects a big portion of the population, and their incidence is on the rise as a result of dietary changes, obesity, and dehydration. As the number of people diagnosed with kidney stones increases, so does the demand for efficient treatment alternatives, which drives the need for better urology surgical instruments.

Furthermore, the emphasis on early detection and preventative care is driving market growth. In July 2024, the American Urological Association (AUA) stressed the necessity of implementing improved diagnostic methods for early diagnosis of kidney stones, allowing for prompt and successful treatment. This endorsement leads to higher acceptance of urological devices designed for both diagnosis and treatment, which drives market growth as healthcare professionals engage in cutting-edge technologies to efficiently manage the growing incidence of urolithiasis.

Urinary incontinence is the fastest-growing area, thanks to increased awareness and advances in surgical procedures including implanted devices and neuromodulation therapies. The growing older population and improved diagnostic tools are driving strong growth in this category, as more patients seek effective urinary incontinence treatments.

Country/Region-wise

Will High Adoption Rate of New Technologies in North America Drive the Urology Surgical Devices Market?

North America's strong acceptance rate of new technologies is projected to significantly drive the urological surgical devices market. North America, notably the United States and Canada, has a well-established healthcare infrastructure and a strong commitment to incorporating innovative technologies into clinical practice. The region's commitment to innovation and research results in rapid adoption of cutting-edge surgical equipment, boosting market growth by fulfilling the growing need for innovative and effective urological treatments.

In April 2024, the American Urological Association (AUA) published a report on the increasing usage of robotic-assisted surgical equipment for urological surgeries in North America. This survey noted a significant growth in the usage of these systems, which are driven by their capacity to provide more precision and better patient outcomes. The AUA's findings highlight the region's excitement for adopting new technology, which stimulates demand for innovative urology surgical instruments and propels market growth.

Will Rising Awareness of Urological Conditions in Asia-Pacific Propel the Urology Surgical Devices Market?

The growing awareness of urological problems in the Asia-Pacific region is likely to drive the urology surgical instruments market. As healthcare knowledge grows, more people seek diagnosis and treatment for urological problems, increasing the demand for improved surgical technologies. The increased emphasis on education and public health initiatives is helping to eliminate the stigma associated with certain disorders and promote early diagnosis, resulting in higher market growth.

For instance, in June 2024, the World Health Organization (WHO) announced a new program to raise awareness of urological health issues throughout the Asia-Pacific area. This campaign includes educational initiatives and screenings, which are expected to drive up demand for urological diagnostics and surgical technologies. The WHO's emphasis on improving access to care and early intervention is predicted to boost market growth by increasing the number of procedures performed and the use of new technology.

In July 2024, Medtronic also announced a strategic agreement with local health authorities in Asia-Pacific to increase the availability of its urological surgical equipment in emerging areas. This collaboration intends to meet the growing need for innovative surgical solutions in these regions, and it is projected to increase market penetration. This approach coincides with increased awareness and growing healthcare demands in the region by improving the availability of high-quality urological equipment and supporting local healthcare infrastructure, driving market expansion even further.

Competitive Landscape

The competitive landscape of the urology surgical devices market is characterized by rapid technological advancements and a focus on innovation. Companies are continuously developing new devices with enhanced precision, minimally invasive techniques, and improved patient outcomes. The market sees a mix of large multinational corporations and specialized firms, all striving to differentiate themselves through product differentiation, strategic partnerships, and expanding their product portfolios to address a broad range of urological conditions. Additionally, increasing adoption of robotic-assisted surgeries and advancements in imaging technologies are shaping the competitive dynamics.

Some of the prominent players operating in the urology surgical devices market include:

Olympus

Boston Scientific

Medtronic

Teleflex

Karl Storz

Coloplast

Conmed

Stryker

Cook Medical

Latest Developments

In May 2024, Boston Scientific purchased a urology device startup that offers new, minimally invasive therapies for urine incontinence. This acquisition will enable Boston Scientific to broaden its product offerings and incorporate cutting-edge technologies into its urology portfolio.

In July 2024, Fresenius Medical Care developed an improved dialysis device for urological applications, aimed at better patient treatment of chronic kidney disease. This device incorporates advanced filtration technology to help address urological issues caused by kidney disease.

In March 2024, Coloplast developed a novel urological catheter with enhanced materials and design characteristics to reduce infection rates and improve patient comfort. The catheter is intended to enhance the overall experience for patients who require long-term catheterization.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Urology Surgical Devices Market, By Procedure Type

• Nephrectomy
• Cystectomy
• Prostatectomy
• Ureteroscopy
• Lithotripsy
• Bladder Suspension Procedures
• Transurethral Resection of the Prostate (TURP)

5. Urology Surgical Devices Market, By End User

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)

6. Urology Surgical Devices Market, By Application

• Benign Prostatic Hyperplasia (BPH)
• Urolithiasis (Kidney Stones)
• Prostate Cancer
• Urinary Incontinence

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Olympus
• Boston Scientific
• Medtronic
• Teleflex
• Karl Storz
• Richard Wolf
• Coloplast
• Conmed
• Stryker
• Cook Medical

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References